ConductScience.org, home

Paper10467366

Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.

Kokoris MS and 3 others. Gene Ther, 1999. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Papers, record 10467366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10467366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
PubMed
Journal
Gene Ther
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
1.83
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kokoris MSM S
2Sabo PP
3Adman ETE T
4Black MEM E

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TherapyMajor topic
GliomaMajor topic
Herpesvirus 1, HumanMajor topic
Thymidine KinaseMajor topic
Acyclovir
Amino Acid Sequence
Animals
Ganciclovir
Gene Transfer Techniques
Genetic Vectors
Mice
Mice, Nude
Models, Molecular
Molecular Sequence Data
Mutation
Neoplasm Transplantation
Prodrugs
Rats
Transfection
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 ES07033NIEHS NIH HHSUnited StatesP30ES007033PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17548276The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.Hum Gene Ther1995https://conductscience.org/library/papers/7548276PubMed
27621241Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells.Cancer Gene Ther1994https://conductscience.org/library/papers/7621241PubMed
32273392Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation.J Gen Virol1990https://conductscience.org/library/papers/2273392PubMed
48527482
Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.
Hum Gene Ther1995https://conductscience.org/library/papers/8527482PubMed
563066649-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6306664PubMed
61317968In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.Science1992https://conductscience.org/library/papers/1317968PubMed
78221662The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.Cancer Res1993https://conductscience.org/library/papers/8221662PubMed
87831805Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription.Virology1995https://conductscience.org/library/papers/7831805PubMed
98018748Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system.Hum Gene Ther1994https://conductscience.org/library/papers/8018748PubMed
103093688Glial culture on artificial capillaries: electron microscopic comparisons of C6 rat glioma cells and rat astroglia.J Neurosci Res1986https://conductscience.org/library/papers/3093688PubMed
118058777Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8058777PubMed
128159705Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8159705PubMed
131335091Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.J Neurosci Res1992https://conductscience.org/library/papers/1335091PubMed
142299679Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.J Natl Cancer Inst1990https://conductscience.org/library/papers/2299679PubMed
151318167Characteristics of C6 glioma cells overexpressing a gap junction protein.Cell Mol Neurobiol1992https://conductscience.org/library/papers/1318167PubMed
169095411
A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients.
Hum Gene Ther1997https://conductscience.org/library/papers/9095411PubMed
176248551Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase.J Biol Chem1980https://conductscience.org/library/papers/6248551PubMed
182553730Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition.J Biol Chem1989https://conductscience.org/library/papers/2553730PubMed
199498487Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.J Natl Cancer Inst1998https://conductscience.org/library/papers/9498487PubMed
201313013Permissible amino acid substitutions within the putative nucleoside binding site of herpes simplex virus type 1 encoded thymidine kinase established by random sequence mutagenesis [corrected].J Biol Chem1992https://conductscience.org/library/papers/1313013PubMed

See all 36 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
41809368Intravenous oncolytic vaccinia expressing transgenes for enhanced safety, inhibition of shedding, imaging, and systemic cancer immunotherapy.Mol Ther Oncol2026https://conductscience.org/library/papers/41809368PubMed
35402634Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles.Mol Ther Methods Clin Dev2022https://conductscience.org/library/papers/35402634PubMed
25824605Liver-targeted gene therapy: Approaches and challenges.Liver Transpl2015https://conductscience.org/library/papers/25824605PubMed
24231389Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.DNA Repair (Amst)2013https://conductscience.org/library/papers/24231389PubMed
22384805Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.Curr Gene Ther2012https://conductscience.org/library/papers/22384805PubMed
20020177Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth.J Neurooncol2010https://conductscience.org/library/papers/20020177PubMed
19763147Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.Cancer Gene Ther2010https://conductscience.org/library/papers/19763147PubMed
18949076The role of herpes simplex virus-1 thymidine kinase alanine 168 in substrate specificity.Open Biochem J2008https://conductscience.org/library/papers/18949076PubMed
18291415Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.J Mol Biol2008https://conductscience.org/library/papers/18291415PubMed
17853921Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.Cancer Gene Ther2007https://conductscience.org/library/papers/17853921PubMed
17658449A method for quantification of nucleotides and nucleotide analogues in thymidine kinase assays using lanthanum phosphate coprecipitation.Anal Biochem2007https://conductscience.org/library/papers/17658449PubMed
17581598Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.Gene Ther2007https://conductscience.org/library/papers/17581598PubMed
16964432A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy.Int J Mol Med2006https://conductscience.org/library/papers/16964432PubMed
16885999Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants.Gene Ther2007https://conductscience.org/library/papers/16885999PubMed
16810197A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing.Gene Ther2006https://conductscience.org/library/papers/16810197PubMed
15818381Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.Cancer Gene Ther2005https://conductscience.org/library/papers/15818381PubMed
15729368VP22-mediated intercellular transport for suicide gene therapy under oxic and hypoxic conditions.Gene Ther2005https://conductscience.org/library/papers/15729368PubMed
15592447Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.Cancer Gene Ther2005https://conductscience.org/library/papers/15592447PubMed
15483667Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase.Gene Ther2005https://conductscience.org/library/papers/15483667PubMed
12869307Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.Neoplasia2003https://conductscience.org/library/papers/12869307PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10467366

GET https://conductscience.org/api/papers/v1/10467366/references?page=2